Drowning in Alerts: How AI Is Redefining What Deserves Clinical Attention in Remote Monitoring - Powered by Implicity-Drowning in Alerts: How AI Is Redefining What Deserves Clinical Attention in Remote Monitoring

Drowning in Alerts: How AI Is Redefining What Deserves Clinical Attention in Remote Monitoring - Powered by Implicity

Video Transcription

Video Summary

The session discussed the growing role of AI in cardiac electrophysiology and remote monitoring, especially for implantable devices and loop recorders. The panel introduced differing views on regulation, clinical responsibility, and real-world performance of AI tools. Arnaud Rosier explained why he pursued CE marking and FDA clearance: to ensure AI technologies could safely be applied to patients. Josh Lampert emphasized that AI should be regulated, but that regulation must be tailored to specific clinical use cases and workflows, since population-level metrics often do not reflect individual patient risk.  <br /><br />The group debated false positives, false negatives, and the challenge of comparing algorithms across devices and manufacturers. Several panelists noted that AI can help reduce data overload, but must not hide important events or replace physician judgment. David Dunker described Europe’s stricter regulatory environment, which he said can hinder implementation of AI in clinical practice.  <br /><br />A major theme was auditability: clinicians need to know not only whether a model made a prediction, but whether the full system functioned correctly. The discussion concluded with cautious optimism: AI is necessary to manage growing data volumes, but it must be transparent, clinically useful, and grounded in the physician’s duty to “do no harm.”

Keywords

AI in electrophysiology

remote monitoring

implantable devices

loop recorders

FDA clearance

CE marking

false positives and false negatives

clinical auditability